Convenience Store Brands Like 7-Eleven Need Unique Marketing to Thrive

 
7-Eleven launched their fourth year of “Brands with Heart” partnering with local and smaller companies to stock the 7-Eleven shelves with unique brands that will continue to draw consumers into their convenience store. “Brands with Heart” give not only 7-Elevens a way to stand out against other convenience stores, but it also draws attention to some great small businesses that otherwise would not get this type of exposure.

As the world changes and more convenience store chains pop up as well as fast food, every brand of food and even convenience store needs something that sets them apart from the rest to draw in business. Why as a consumer would you choose a 7-Eleven over a Shell when they are right next to one another?

Sabine Benoit, Professor of Marketing at the University of Surrey, discusses her 4 reasons as to why the 7-Eleven local brand partnerships is a good idea.

Sabine’s Thoughts

“Hi there. My name is Sabine Benoit. I’m professor of marketing at the University of Surrey, specializing on convenience retailing. 7-Eleven partnering with local brands is, in my view, a good idea for four reasons. One is that the customer and the market push for sustainability and consumers understand that global brands very often travel a long way to be on the shelf.

Number two is the push for differentiation. 7-Eleven always used to be differentiated. Convenience and through being near to the consumer and in good locations, now many other retailers and many other players are moving into that space of food to go on the go consumption. And therefore, I think the differentiation has to have a different facet for seven-eleven and local brands is one possibility.

So, these are the two market-oriented reasons. The two internal reasons are negotiation power, of course, collaborating. Local brands on gives the seven 11 a better negotiation position and negotiations get tougher when economy and when prices rise for raw materials. And the other thing is that pricing can be much more variable.

So, in times of rising raw materials and squash on profitability, local brands give the retailer a little bit more leeway when it comes to pricing and adjusting profitability that were my reasons for why I think that’s a good idea.”

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More